By Ben GlickmanShares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was up 19% at 90 cents in midday trading. Shares are up more than 50% over the last three months.

Source: Wall Street Journal January 02, 2024 17:55 UTC